Conget I - Search Results

1

The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial.

Gerstein HC, Hart R, Colhoun HM, Diaz R, Lakshmanan M, Botros FT, Probstfield J, Riddle MC, Rydén L, Atisso CM, Dyal L, Hall S, Avezum A, Basile J, Conget I, Cushman WC, Hancu N, Hanefeld M, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Muñoz EGC, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T. Gerstein HC, et al. Among authors: conget i. Lancet Diabetes Endocrinol. 2020 Feb;8(2):106-114. doi: 10.1016/S2213-8587(19)30423-1. Epub 2020 Jan 7. Lancet Diabetes Endocrinol. 2020. PMID: 31924562 Clinical Trial.

2

Insulin lispro is as effective as regular insulin in optimising metabolic control and preserving beta-cell function at onset of type 1 diabetes mellitus.

Recasens M, Aguilera E, Morínigo R, Casamitjana R, Nicoletti F, Gomis R, Conget I. Recasens M, et al. Among authors: conget i. Diabetes Res Clin Pract. 2003 Jun;60(3):153-9. doi: 10.1016/s0168-8227(03)00036-6. Diabetes Res Clin Pract. 2003. PMID: 12757987 Clinical Trial.

3

Improving metabolic control in sub-optimally controlled subjects with Type 1 diabetes: comparison of two treatment algorithms using insulin glargine.

Gomis R, Storms F, Conget I, Sinnassamy P, Davies M; AT.LANTUS Study Group. Gomis R, et al. Among authors: conget i. Diabetes Res Clin Pract. 2007 Jul;77(1):84-91. doi: 10.1016/j.diabres.2006.10.002. Epub 2006 Nov 9. Diabetes Res Clin Pract. 2007. PMID: 17097185 Clinical Trial.

4

Repeated episodes of hypoglycemia as a potential aggravating factor for preclinical atherosclerosis in subjects with type 1 diabetes.

Giménez M, Gilabert R, Monteagudo J, Alonso A, Casamitjana R, Paré C, Conget I. Giménez M, et al. Among authors: conget i. Diabetes Care. 2011 Jan;34(1):198-203. doi: 10.2337/dc10-1371. Epub 2010 Oct 7. Diabetes Care. 2011. PMID: 20929996 Free PMC article.

5

Incidence of diabetes following ramipril or rosiglitazone withdrawal.

DREAM Trial Investigators. DREAM Trial Investigators. Diabetes Care. 2011 Jun;34(6):1265-9. doi: 10.2337/dc10-1567. Epub 2011 Apr 22. Diabetes Care. 2011. PMID: 21515846 Free PMC article. Clinical Trial.

6

Design, history and results of the Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) randomised controlled trial.

Punthakee Z, Bosch J, Dagenais G, Diaz R, Holman R, Probstfield J, Ramachandran A, Riddle M, Rydén LE, Zinman B, Afzal R, Yusuf S, Gerstein H; TIDE Trial Investigators. Punthakee Z, et al. Diabetologia. 2012 Jan;55(1):36-45. doi: 10.1007/s00125-011-2357-4. Epub 2011 Oct 29. Diabetologia. 2012. PMID: 22038523 Clinical Trial.

7

OpT2mise: a randomized controlled trial to compare insulin pump therapy with multiple daily injections in the treatment of type 2 diabetes-research design and methods.

Aronson R, Cohen O, Conget I, Runzis S, Castaneda J, de Portu S, Lee S, Reznik Y; OpT2mise Study Group. Aronson R, et al. Among authors: conget i. Diabetes Technol Ther. 2014 Jul;16(7):414-20. doi: 10.1089/dia.2013.0363. Epub 2014 Apr 15. Diabetes Technol Ther. 2014. PMID: 24735134 Clinical Trial.

8

Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial.

Reznik Y, Cohen O, Aronson R, Conget I, Runzis S, Castaneda J, Lee SW; OpT2mise Study Group. Reznik Y, et al. Among authors: conget i. Lancet. 2014 Oct 4;384(9950):1265-72. doi: 10.1016/S0140-6736(14)61037-0. Epub 2014 Jul 2. Lancet. 2014. PMID: 24998009 Clinical Trial.

9

Detailed description of a prepregnancy care program and its impact on maternal glucose control, weight gain, and dropouts.

Perea V, Orois A, Amor AJ, Jansà M, Vidal M, Gimenez M, Conget I, Vinagre I. Perea V, et al. Among authors: conget i. Diabetes Metab Res Rev. 2017 Feb;33(2). doi: 10.1002/dmrr.2838. Epub 2016 Aug 18. Diabetes Metab Res Rev. 2017. PMID: 27385384 Clinical Trial.

10

Design and baseline characteristics of participants in the Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) trial on the cardiovascular effects of dulaglutide.

Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riddle MC, Rydén L, Xavier D, Atisso CM, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona-Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw J, Sheu WH, Temelkova-Kurktschiev T; REWIND Trial Investigators. Gerstein HC, et al. Among authors: conget i. Diabetes Obes Metab. 2018 Jan;20(1):42-49. doi: 10.1111/dom.13028. Epub 2017 Jul 14. Diabetes Obes Metab. 2018. PMID: 28573765 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

224 results

Search Page